LOS ANGELES (AP) — California has transformed into a major player in stem cell research, but the taxpayer-funded institute responsible has “significant deficiencies” in how research dollars are distributed, experts said Thursday.
A report by the Institute of Medicine found too many members on the board of the California Institute for Regenerative Medicine represented schools that won funding and recommended a restructuring to avoid the appearance of conflict of interest.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.